Patent 8153804 was granted and assigned to Lexicon Pharmaceuticals, Inc. on April, 2012 by the United States Patent and Trademark Office.
Aryl pyridines, compositions comprising them, and methods of their use for the treatment, prevention and management of a variety of diseases and disorders are disclosed.